A protein that protects the lungs against pathogens has the potential to thwart SARS-CoV-2, which causes COVID-19, National Cheng Kung University (NCKU) researchers have said.
The discovery, made by a team led by university professor Wang Jiu-yao (王志堯), was published by Frontier in Immunology, a peer-reviewed scientific journal, on Tuesday last week.
The human surfactant protein D (SP-D) is a molecule whose presence on the mucosal surfaces of the lungs plays “an immune surveillance role against pulmonary pathogens,” the university said in a statement, citing the team.
People with SARS have been reported to have higher levels of serum SP-D, which is a known a biomarker of pneumonia and tuberculosis, the team said.
Studies have suggested that serum SP-D can recognize the spike proteins — the protrusions on viruses that give them access to host cells — on SARS-CoV, which causes SARS, and interact with the human coronavirus 229E strain to inhibit viral infection in humans.
Previous studies have also found that a recombinant fragment of human SP-D (rfhSP-D) can act against a range of viral pathogens, including the influenza A virus, the statement said.
Based on the findings, the research team examined whether rfhSP-D could also protect against SARS-CoV-2, and the results were positive, it said.
The team found that the rfhSP-D protein bound to the S1 spike protein of SARS-CoV-2 and inhibited interaction with test cells with angiotensin-converting enzyme 2 (ACE2) receptors, through which SARS-CoV-2 enters host cells.
The rfhSP-D protein had the same protective effect on cultured cells expressing ACE2 that were infected by laboratory-created pseudoviruses, called pseudo typed lentivrial particles, the statement said.
The results highlight the therapeutic potential of rfhSP-D in SARS-CoV-2 infection and merit further study, it said.
FUKUOKA SITUATION: Japanese media reported that the pathogen is expected to be identified by the summer, while the CDC downplayed the idea that it was hMPV A “mysterious cold-like illness” reported in Japan’s Fukuoka Prefecture does not seem to be a new disease, but Japanese authorities have been asked about the situation, the Centers for Disease Control (CDC) said yesterday. The Fukuoka Prefectural Medical Association on Wednesday told a news conference that a “mystery cold” that has become a hot topic on social media is “highly likely to be caused by some kind of viral infection,” Japan’s KBC News reported. “Many people are experiencing symptoms starting with a sore throat, followed by a runny nose, phlegm and a severe cough,” KBC News reported, citing association officials. Health authorities are
Nvidia Corp CEO Jensen Huang (黃仁勳) arrived in Taiwan yesterday ahead of upcoming AI and technology events, saying he plans to meet with clients and Taiwan Semiconductor Manufacturing Co Chairman C.C. Wei (魏哲家) during his visit. After landing at Taipei Songshan Airport, Huang posed for photos with fans and handed out Yakult drinks to reporters and supporters waiting at the scene, saying he has “a lot to do” during the trip. Asked about reports that Nvidia’s planned headquarters site in Taipei’s Beitou Shilin Technology Park could break ground on May 27, Huang said that if the company holds an event, he would
The Ministry of Finance this afternoon announced the winning numbers for the March-April uniform invoice lottery. The winning number for the NT$10 million (US$318,060) special prize is 19531471, and the winning number for the NT$2 million grand prize is 85941329. Three numbers were drawn for the NT$200,000 first prize: 07225810, 20231230 and 83518781. Those with receipts matching the last seven digits of any of the first-prize numbers will win the NT$40,000 second prize, while those matching the last six digits will win the NT$10,000 third prize. Those whose receipts match the last five digits of the first-prize numbers can claim the NT$4,000 fourth prize,
Taiwan Travelogue (臺灣漫遊錄), which earlier this week became the first Taiwanese novel to win the International Booker Prize, is to be adapted into a television series through a Taiwan-Japan coproduction, producer Chang Chen-yu (張辰漁) said yesterday. Chang, a producer at World Softest Production Film Co, wrote on Facebook that the company had been searching for projects with international appeal that retain a strong Taiwanese identity after colleagues and Japanese partners strongly recommended the novel. After reading the book, Chang said he immediately decided to pursue the screen rights. “A great story has the power to transcend time and borders, and connect countless people,”